Aetna modified CPB 0493 for kidney transplantation, effective December 18, 2025. Here's what billing teams need to act on now.
Aetna, a CVS Health company, updated its kidney transplantation coverage policy under CPB 0493 Aetna system on December 18, 2025. This Aetna kidney transplantation coverage policy governs a long list of CPT codes — from the core transplant procedures (50300, 50360, 50365) to donor nephrectomy (50320, 50547) and backbench preparation (50323, 50325) — and explicitly excludes several newer molecular diagnostics tied to rejection monitoring. If your team bills for transplant services or post-transplant monitoring, this update touches your workflow directly.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Aetna |
| Policy | Kidney Transplantation — CPB 0493 |
| Policy Code | CPB 0493 |
| Change Type | Modified |
| Effective Date | December 18, 2025 |
| Impact Level | High |
| Specialties Affected | Nephrology, transplant surgery, urology, oncology, infectious disease, RCM teams billing ESRD and transplant services |
| Key Action | Audit charge capture for donor-derived cell-free DNA codes (0493U, 0508U, 0509U, 0540U, 0544U) — Aetna does not cover these for kidney transplant indications |
Aetna Kidney Transplantation Coverage Criteria and Medical Necessity Requirements 2025
The real issue with this coverage policy is the layered criteria structure. Aetna defers to the transplanting institution's selection criteria first. If your institution has a documented protocol, that governs. If it doesn't, Aetna's own criteria apply — and they're specific.
Medical necessity for kidney transplantation requires all of the following:
| # | Covered Indication |
|---|---|
| 1 | Transplant committee acceptance: The member must complete a full evaluation and be accepted by the kidney transplant committee at the transplanting center. Aetna flags a common error here: requests for transplant evaluation are frequently confused with requests for transplantation itself. Evaluation may be covered; the transplant's medical necessity depends on what that evaluation finds. |
| 2 | Age eligibility: The member must meet the transplanting institution's protocol criteria for age. |
| 3 | Malignancy status: No active malignancy — except non-melanomatous skin cancers or low-grade prostate cancer. Curative therapy counts if the estimated recurrence risk is below 10% within two years. Examples from the policy include renal cell carcinoma with no metastatic evidence two years post-nephrectomy, prostate cancer with undetectable PSA after treatment, and thyroid cancer with normal thyroglobulin. Female candidates need a negative Pap smear within three years and mammography (CPT 77053, 77054) within two years where indicated. |
| 4 | No systemic infection. |
| 5 | HIV criteria (all four must be met): CD4 count above 200 cells/mm³ for more than six months; undetectable HIV-1 RNA (viral load); stable antiviral therapy for more than three months; no AIDS complications such as opportunistic infections, Kaposi's sarcoma, or other neoplasms. |
| 6 | Cardiovascular, pulmonary, and hepatic risk: The attending physician must determine there is no prohibitive risk in any of these three categories. |
| 7 | Severity of renal disease: The member must meet one of the following — already on hemodialysis or CAPD (CPT 90918–90931 range); chronic renal failure with anticipated progression to ESRD and seeking precertification for cadaveric transplant (creatinine clearance below 30 ml/min qualifies, given cadaveric wait times of one to four years); or ESRD evidenced by creatinine clearance below 20 ml/min or uremic symptoms, when seeking precertification for living donor transplant. |
The cadaveric vs. living donor distinction matters for prior authorization. Aetna treats precertification for cadaveric transplant differently from living donor — make sure your PA requests reflect the correct pathway.
Kidney transplant reimbursement under this policy depends on meeting every criterion above. One missing element — an incomplete HIV workup, a malignancy recurrence risk above 10%, a missing transplant committee acceptance — and you're looking at a claim denial.
Aetna Kidney Transplantation Exclusions and Non-Covered Indications
Kidney transplantation is not medically necessary — per the policy — when the member does not meet the transplanting institution's protocol selection criteria. In the absence of a protocol, Aetna lists absolute contraindications. These include:
| # | Excluded Procedure |
|---|---|
| 1 | Active vasculitis |
| 2 | Age over 70 with severe comorbidities |
| 3 | Life-threatening extra-renal congenital abnormalities |
| 4 | Ongoing alcohol or drug abuse |
The policy notes this is not an all-inclusive list. That's a red flag for billing teams. Document everything. If a claim comes back denied for a reason not on this list, you have grounds to appeal — but only if your documentation shows the absence of every listed exclusion.
The bigger story in the exclusions section is the molecular diagnostics. Aetna does not cover donor-derived cell-free DNA testing — marketed under names like Allosure — for kidney transplant indications. The excluded codes are 0493U, 0508U, 0509U, 0540U, and 0544U. This is a firm "not covered" designation, not a frequency limit or quantity restriction. If you're billing these for Aetna members, stop and reassess.
Similarly, these codes are excluded: 0088U (microarray gene expression profiling for allograft rejection), 0526U (CXCL10 chemokine quantification by flow cytometry), 0542U (NMR spectroscopy for renal transplant monitoring), 81558 (mRNA gene expression profiling for allograft rejection), 83520 (immunoassay for CXCL9 or related analytes), and 85415 (plasminogen activator). None of these are covered for the indications in CPB 0493.
Abdominoplasty codes 15830 and 15847 are also explicitly not covered in this context.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Kidney transplantation — cadaveric donor | Covered | 50300, 50323, 50360, 50365 | All medical necessity criteria must be met; precertification required |
| Kidney transplantation — living donor (open) | Covered | 50320, 50325, 50360, 50365 | Creatinine clearance below 20 ml/min or uremic symptoms required |
| Kidney transplantation — living donor (laparoscopic) | Covered | 50547, 50325 | Same severity criteria as open living donor |
| Backbench preparation and reconstruction | Covered | 50323, 50325, 50327, 50328, 50329 | Covered when transplant itself meets selection criteria |
| Recipient nephrectomy | Covered | 50340, 50365 | Covered as part of transplant procedure |
| Renal allograft removal | Covered | 50370 | Covered when criteria met |
| Renal autotransplantation | Covered | 50380 | Covered when criteria met |
| ESRD dialysis services (pre-transplant) | Related | 90918–90931 | Related to transplant candidacy documentation |
| Female screening (Pap, mammography) | Required for eligibility | 77053, 77054, 88141–88175 | Must be current; mammography within 2 years, Pap within 3 years |
| Donor-derived cell-free DNA testing (e.g., Allosure) | Not Covered | 0493U, 0508U, 0509U, 0540U, 0544U | No specific covered indication under CPB 0493 |
| Allograft rejection microarray profiling | Not Covered | 0088U, 81558 | Not covered for indications in CPB 0493 |
| CXCL10 quantification by flow cytometry | Not Covered | 0526U | Not covered for indications in CPB 0493 |
| NMR spectroscopy renal transplant monitoring | Not Covered | 0542U | Not covered for indications in CPB 0493 |
| Immunoassay (CXCL9 and related) | Not Covered | 83520 | Not covered for indications in CPB 0493 |
| Plasminogen activator | Not Covered | 85415 | Not covered for indications in CPB 0493 |
| DNA methylation biomarker (pre/post transplant) | Policy addressed — no specific coverage | 0018M, 0319U, 0320U | Listed under separate DNA methylation section; not specifically covered |
| Abdominoplasty / panniculectomy | Not Covered | 15830, 15847 | Not covered for indications in CPB 0493 |
Aetna Kidney Transplantation Billing Guidelines and Action Items 2025
| # | Action Item |
|---|---|
| 1 | Audit your charge capture for cell-free DNA codes immediately. Pull claims billed under 0493U, 0508U, 0509U, 0540U, and 0544U for Aetna members. Any that went out after December 18, 2025 under a kidney transplant indication are at high risk for denial or recoupment. Stop billing these codes for Aetna transplant patients unless coverage changes. |
| 2 | Separate transplant evaluation requests from transplant authorization requests. Aetna calls this out directly in CPB 0493. Your prior authorization team needs to flag this distinction in their workflow. If you're submitting a PA for transplant, the evaluation must already be complete — and the committee acceptance documented. |
| 3 | Verify malignancy recurrence risk documentation before submitting precertification. The 10% threshold within two years is specific. Your clinical team needs to document this explicitly — not just note a cancer history. For female candidates, confirm mammography (77053 or 77054) and cytopathology (88141–88175 range) results are current before the PA goes in. |
| 4 | Check HIV workup completeness for HIV-positive candidates. All four criteria must be in the record: CD4 count above 200 cells/mm³ for more than six months, undetectable HIV-1 RNA, stable antiviral therapy for more than three months, and no AIDS complications. Missing one of these will kill the authorization. |
| 5 | Differentiate cadaveric vs. living donor pathways in your PA requests. The severity thresholds differ. Cadaveric transplant precertification covers chronic renal failure with creatinine clearance below 30 ml/min. Living donor requires creatinine clearance below 20 ml/min or active uremic symptoms. Submit the wrong pathway and you're starting over. |
| 6 | Pull your 0018M, 0319U, and 0320U claims for review. These DNA methylation codes sit in a gray zone — the policy addresses them under a separate section without explicit covered status. If your team has been billing these for Aetna kidney transplant patients, loop in your compliance officer before the next billing cycle. |
| 7 | Update your billing guidelines documentation for transplant coordinators. This policy has enough nuance — especially around malignancy criteria, HIV requirements, and the cadaveric vs. living donor split — that verbal handoffs will cause errors. Get it in writing and train the team before December 18, 2025 is fully in the rearview. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Kidney Transplantation Under CPB 0493
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 50300 | CPT | Donor nephrectomy, including cold preservation; from cadaver donor, unilateral or bilateral |
| 50320 | CPT | Donor nephrectomy, including cold preservation; open from living donor |
| 50323 | CPT | Backbench standard preparation of cadaver donor renal allograft prior to transplantation |
| 50325 | CPT | Backbench standard preparation of living donor renal allograft (open or laparoscopic) prior to transplantation |
| 50327 | CPT | Backbench reconstruction of cadaver or living donor renal allograft; venous anastomosis |
| 50328 | CPT | Backbench reconstruction; arterial anastomosis, each |
| 50329 | CPT | Backbench reconstruction; ureteral anastomosis, each |
| 50340 | CPT | Recipient nephrectomy (separate procedure) |
| 50360 | CPT | Renal allotransplantation, implantation of graft; without recipient nephrectomy |
| 50365 | CPT | Renal allotransplantation, implantation of graft; with recipient nephrectomy |
| 50370 | CPT | Removal of transplanted renal allograft |
| 50380 | CPT | Renal autotransplantation, reimplantation of kidney |
| 50547 | CPT | Laparoscopy, surgical; donor nephrectomy including cold preservation, from living donor |
Not Covered CPT Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| 15830 | CPT | Excision, excessive skin and subcutaneous tissue (includes lipectomy); abdomen, infraumbilical panniculectomy | Not covered for indications listed in CPB 0493 |
| 15847 | CPT | Excision, excessive skin and subcutaneous tissue (includes lipectomy), abdomen (e.g., abdominoplasty) | Not covered for indications listed in CPB 0493 |
| 0088U | CPT | Transplantation medicine (kidney allograft rejection), microarray gene expression profiling of 1,494 genes | Not covered for indications listed in CPB 0493 |
| 0526U | CPT | Nephrology (renal transplant), quantification of CXCL10 chemokines, flow cytometry, urine | Not covered for indications listed in CPB 0493 |
| 0542U | CPT | Nephrology (renal transplant), urine, NMR spectroscopy measurement | Not covered for indications listed in CPB 0493 |
| 81558 | CPT | Transplantation medicine (allograft rejection, kidney), mRNA, gene expression profiling by quantitative RT-PCR | Not covered for indications listed in CPB 0493 |
| 83520 | CPT | Immunoassay for analyte other than infectious agent antibody or antigen; quantitative | Not covered for indications listed in CPB 0493 |
| 85415 | CPT | Fibrinolytic factors and inhibitors; plasminogen activator | Not covered for indications listed in CPB 0493 |
Donor-Derived Cell-Free DNA Codes — No Specific Covered Indication
| Code | Type | Description |
|---|---|---|
| 0493U | CPT | Transplantation medicine, quantification of donor-derived cell-free DNA (cfDNA) using next-generation sequencing |
| 0508U | CPT | Transplantation medicine, quantification of donor-derived cell-free DNA using 40 single-nucleotide polymorphisms |
| 0509U | CPT | Transplantation medicine, quantification of donor-derived cell-free DNA using up to 12 single-nucleotide polymorphisms |
| 0540U | CPT | Transplantation medicine, quantification of donor-derived cell-free DNA using next-generation sequencing |
| 0544U | CPT | Nephrology (transplant monitoring), 48 variants by digital PCR, using cell-free DNA from plasma |
DNA Methylation Biomarker Codes — Policy Addressed, Coverage Status Unclear
| Code | Type | Description |
|---|---|---|
| 0018M | CPT | Transplantation medicine (allograft rejection, renal), measurement of donor and third-party-induced immune responses |
| 0319U | CPT | Nephrology (renal transplant), RNA expression by select transcriptome sequencing, using pretransplant sample |
| 0320U | CPT | Nephrology (renal transplant), RNA expression by select transcriptome sequencing, using post-transplant sample |
Get the Full Picture for CPT 77053
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.